Study identification

PURI

https://redirect.ema.europa.eu/resource/45701

EU PAS number

EUPAS30506

Study ID

45701

Official title and acronym

Osteoporosis outcomes and treatment patterns in France (20190017)

DARWIN EU® study

No

Study countries

France

Study description

This is a retrospective cohort study in the National healthcare data system (Système National des Données de Santée - SNDS) containing French nationwide claims and hospital database including postmenopausal women receiving treatment for osteoporosis. The research question is to assess the treatment patterns and the impact of osteoporosis medication on fracture incidence in France. The primary objective is to assess the change in fracture risk after treatment initiation among post-menopausal women receiving osteoporosis treatment, overall and stratified by type of treatment and type of fracture

Study status

Finalised
Research institution and networks

Institutions

Contact details

Pauline Bosco-Levy (Prince)

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Data collection

Planned:
Actual:

Start date of data analysis

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Amgen
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable